ALBHF (Alibaba Health Information Technology) Debt-to-Equity: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ALBHF Alibaba Health Information Technology Ltd ALBHF
53 GF Score
Price $0.44
GF Value $0.69
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Alibaba Health Information Technology Debt-to-Equity?

Alibaba Health Information Technology ALBHF +1.57% 53 Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus rates ALBHF with a GF Score™ of 53/100 and a GF Value™ of $0.69 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 558 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks worse than 179211.29% on this metric.

Alibaba Health Information Technology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $4 Mil. Alibaba Health Information Technology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $4 Mil. Alibaba Health Information Technology's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $2,591 Mil. Alibaba Health Information Technology's debt to equity for the quarter that ended in Mar. 2026 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Alibaba Health Information Technology's Debt-to-Equity or its related term are showing as below:

During the past 13 years, the highest Debt-to-Equity Ratio of Alibaba Health Information Technology was 0.61. The lowest was 0.00. And the median was 0.01.

ALBHF's Debt-to-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.42
* Ranked among companies with meaningful Debt-to-Equity only.

Alibaba Health Information Technology  (OTCPK:ALBHF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Alibaba Health Information Technology Debt-to-Equity Related Terms


Alibaba Health Information Technology Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Alibaba Health Information Technology's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alibaba Health Information Technology Debt-to-Equity Chart

Alibaba Health Information Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.01 0.00 0.00

Alibaba Health Information Technology Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.00 0.00 0.00 0.00

Alibaba Health Information Technology Debt-to-Equity Competitor Comparison

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alibaba Health Information Technology Debt-to-Equity vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's Debt-to-Equity falls into.


ALBHF
53GF Score
Alibaba Health Information Technology Ltd ALBHF
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alibaba Health Information Technology Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Alibaba Health Information Technology's Debt to Equity Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Alibaba Health Information Technology's Debt to Equity Ratio for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of 0.00 mean?
Alibaba Health Information Technology (ALBHF) has a Debt-to-Equity of 0.00 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Alibaba Health Information Technology and its competitors. According to the industry distribution chart, Alibaba Health Information Technology ranks #999999 out of 558 companies in the Healthcare Providers & Services industry.
Is Alibaba Health Information Technology's Debt-to-Equity too high?
Alibaba Health Information Technology's current Debt-to-Equity is 0.00. Based on the distribution chart, Alibaba Health Information Technology ranks #999999 out of 558 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Alibaba Health Information Technology has a GF Score™ of 53/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's Debt-to-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #999999 out of 558 companies for Debt-to-Equity. This places Alibaba Health Information Technology in the lower half of its industry. The industry median Debt-to-Equity is 0.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.42, based on 558 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.69, compared to a current price of $0.44 — trading 36.2% below its estimated fair value. The current Debt-to-Equity is 0.00. Alibaba Health Information Technology's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?

Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued. The current stock price of $0.44 is trading 36.2% below its estimated GF Value™ of $0.69. GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.

Key valuation signals for ALBHF:

  • Debt-to-Equity: 0.00
  • GF Value™: $0.69 vs. price of $0.44 (36.2% below fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alibaba Health Information Technology Business Description

Address Wangjing East Park, 30th Floor, Greenland Center, Building 9, Zone 4, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
53GF Score

Get the complete analysis for ALBHF

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price
$0.69
GF Value